Regulation of antigen presentation machinery in human dendritic cells by recombinant adenovirus

Cancer Immunology, Immunotherapy

Volumn 58, Issue 1, 2009, Pages 121-133

  Vujanovic, Lazar ^a   Whiteside, Theresa L ^b   Potter, Douglas M ^c   Chu, Jessica ^b   Ferrone, Soldano ^a,b   Butterfield, Lisa H ^a,b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c Biostatistics Facility   (United States)

Author keywords

Antigen presentation processing; Dendritic cells; Gene therapy; Human; Tumor immunity

Indexed keywords

ADENOVIRUS VECTOR; CD86 ANTIGEN; CHAPERONE; CHAPERONE PROTEIN ERP 57; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; PROTEIN TAP 2; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELL MATURATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; LYMPHOCYTE ACTIVATION; RECOMBINANT PROTEINS; TRANSDUCTION, GENETIC;

EID: 54849406164     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0533-2     Document Type: Article

References (54)

1. JF Arthur 1997 A comparison of gene transfer methods in human dendritic cells Cancer Gene Ther 4 1 17 25
2. LH Butterfield 1998 Generation of melanoma-specific cytotoxic T lymphocytes by dendritic cells transduced with a MART-1 adenovirus J Immunol 161 10 5607 5613
3. J Diao 1999 Human PBMC-derived dendritic cells transduced with an adenovirus vectorinduce cytotoxic T-lymphocyte responses against a vector-encoded antigen in vitro Gene Ther 6 5 845 853
4. A Lundqvist 2002 Recombinant adenovirus vector activates and protects human monocyte-derived dendritic cells from apoptosis Hum Gene Ther 13 13 1541 1549
5. L Schumacher 2004 Human dendritic cell maturation by adenovirus transduction enhances tumor antigen-specific T-cell responses J Immunother 27 3 191 200
6. M Perreau 2007 Contrasting effects of human, canine, and hybrid adenovirus vectors on the phenotypical and functional maturation of human dendritic cells: implications for clinical efficacy J Virol 81 7 3272 3284
7. PH Tan 2005 Immunolipoplexes: an efficient, nonviral alternative for transfection of human dendritic cells with potential for clinical vaccination Mol Ther 11 5 790 800
8. Y He 2005 Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity J Immunol 174 6 3808 3817
9. P Metharom KA Ellem MQ Wei 2005 Gene transfer to dendritic cells induced a protective immunity against melanoma Cell Mol Immunol 2 4 281 288
10. M Nakamura 2005 Dendritic cells transduced with tumor-associated antigen gene elicit potent therapeutic antitumor immunity: comparison with immunodominant peptide-pulsed DCs Oncology 68 2-3 163 170
11. J Yuan 2005 Langerhans cells derived from genetically modified human CD34+ hemopoietic progenitors are more potent than peptide-pulsed Langerhans cells for inducing antigen-specific CD8+ cytolytic T lymphocyte responses J Immunol 174 2 758 766
12. A Curti 2005 Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells Exp Hematol 33 12 1521 1530
13. M Lotem 2006 Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors J Immunother (1997) 29 6 616 627
14. EB van Leeuwen 2006 Transduction with a fiber-modified adenoviral vector is superior to non-viral nucleofection for expressing tumor-associated Ag mucin-1 in human DC Cytotherapy 8 1 36 46
15. Y Liu 2006 Hierarchy of AFP-specific T cell responses in subjects with AFP-positive hepatocellular cancer J Immunol 177 1 712 721
16. VN Evdokimova 2007 AFP-specific CD4+ helper T-cell responses in healthy donors and HCC patients J Immunother 30 4 425 437
17. J Koch R Tampe 2006 The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation Cell Mol Life Sci 63 653 662
18. M Mishito 2003 Immunoproteasomes and immunosenescence Ageing Res Rev 2 419 432
19. N Connolly 2007 Levels of antigen processing machinery components in dendritic cells generated for vaccination of HIV-1+ subjects Aids 21 13 1683 1692
20. TL Whiteside 2004 Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells J Immunol 173 3 1526 1534
21. IL Tourkova 2005 Restoration by IL-15 of MHC class I antigen-processing machinery in human dendritic cells inhibited by tumor-derived gangliosides J Immunol 175 5 3045 3052
22. MK Callahan 2006 Heat shock up-regulates lmp2 and lmp7 and enhances presentation of immunoproteasome-dependent epitopes J Immunol 177 12 8393 8399
23. M Obeid 2007 Calreticulin exposure dictates the immunogenicity of cancer cell death Nat Med 13 1 54 61
24. M Meissner 2005 Defects in the human leukocyte antigen class I antigen processing machinery in head and neck squamous cell carcinoma: association with clinical outcome Clin Cancer Res 11 7 2552 2560
25. LH Butterfield 1999 Generation of human T-cell responses to an HLA-A2.1-restricted peptide epitope derived from alpha-fetoprotein Cancer Res 59 13 3134 3142
26. N Bandoh 2005 Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies Tissue Antigens 66 3 185 194
27. T Ogino 2003 Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients Clin Cancer Res 9 11 4043 4051
28. X Wang 2005 A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections J Immunol Methods 299 1-2 139 151
29. T Tatsumi 2003 MAGE-6 encodes HLA-DRbeta1*0401-presented epitopes recognized by CD4+ T cells from patients with melanoma or renal cell carcinoma Clin Cancer Res 9 3 947 954
30. T Tatsumi 2002 Disease-associated bias in T helper type 1 (Th1)/Th2 CD4(+) T cell responses against MAGE-6 in HLA-DRB10401(+) patients with renal cell carcinoma or melanoma J Exp Med 196 5 619 628
31. NJ Philpott 2004 Adenovirus-induced maturation of dendritic cells through a PI3 kinase-mediated TNF-alpha induction pathway Proc Natl Acad Sci USA 101 16 6200 6205
32. L Vujanovic 2007 A mycoplasma peptide elicits heteroclitic CD4+ T cell responses against tumor antigen MAGE-A6 Clin Cancer Res 13 22 pt 1 6796 6806
33. L Vujanovic 2006 IL-12p70 and IL-18 gene-modified dendritic cells loaded with tumor antigen-derived peptides or recombinant protein effectively stimulate specific Type-1 CD4+ T-cell responses from normal donors and melanoma patients in vitro Cancer Gene Ther 13 8 798 805
34. LH Butterfield 2001 T cell responses to HLA-A*0201-restricted peptides derived from human alpha fetoprotein J Immunol 166 8 5300 5308
35. S Stager PM Kaye 2004 CD8+ T-cell priming regulated by cytokines of the innate immune system Trends Mol Med 10 8 366 371
36. MA Lowes 1997 T helper 1 cytokine mRNA is increased in spontaneously regressing primary melanoma J Invest Derm 108 914 919
37. T Schwaab 2000 A randomized phase II trial comparing two different sequence combinations of autologous vaccine and human recombinant interferon gamma and human recombinant interferon alpha2B therapy in patients with metastatic renal cell carcinoma: clinical outcome and analysis of immunological parameters J Urol 163 1322 1327
38. HJ Ahn 1997 A mechanism underlying synergy between IL-12 and IFN-gamma-inducing factor in enhanced production of IFN-gamma J Immunol 159 2125 2131
39. NJ Rogers 2003 Cross-species costimulation: relative contributions of CD80, CD86, and CD40 Transplant 75 12 2068 2076
40. NJ Rogers 2003 CD40 can costimulate human memory T cells and favors IL-10 secretion Eur J Immunol 33 1094 1104
41. PE Fields 1998 B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells J Immunol 161 5268 5275
42. CN Manzotti 2006 Integration of CD28 and CTLA-4 Function Results in Differential Responses of T Cells to CD80 and CD86 Eur J Immunol 36 1413 1422
43. A Kienast 2007 Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin Nat Immunol 8 864 872
44. PA Wearsch P Cresswell 2007 Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer Nat Immunol 8 873 881
45. K Fruh 1994 Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex EMBO J 13 3236 3244
46. M Gaczynska 1996 Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7 J Biol Chem 271 17275 17280
47. M Gaczynska 1994 Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7 Proc Natl Acad Sci USA 91 9213 9217
48. K Schwarz 2000 Overexpression of the proteasome subunits LMP2, LMP7, and MECL-1, but not PA28 α/β, enhances the presentation of an immunodominant lymphocytic choriomeningitis virus T cell epitope J Immunol 165 768 778
49. AJAM Sijts 2000 MHC class I antigen processing of an adenovirus CTL epitope is linked to the levels of immunoproteasomes in infected cells J Immunol 164 4500 4506
50. A Macagno 2001 Pronounced up-regulation of the PA28α/β proteasome regulator but little increase in the steady-state content of immunoproteasome during dendritic cell maturation Eur J Immunol 31 3271 3280
51. L Marques 2004 STAT1 regulates lipopolysaccharide- and TNF-alpha-dependent expression of transporter associated with antigen processing 1 and low molecular mass polypeptide 2 genes in macrophages by distinct mechanisms J Immunol 173 2 1103 1110
52. J Li 2001 Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation Int Immunol 13 12 1515 1523
53. A Macagno 1999 Dendritic cells up-regulate immunoproteasomes and the proteasome regulator PA28 during maturation Eur J Immunol 29 4037 4042
54. C Cheng 2007 Mechanism of ad5 vaccine immunity and toxicity: fiber shaft targeting of dendritic cells PLoS Pathog 3 2 e25